LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.18 | 17.25 | 88 | 5031 | 0.0175 | 0.2202 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 60.18 | 17.25 | 8130 | 5031 | 1.6158 | 1.1207 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.15 | 17.25 | 67 | 5061 | 0.0132 | 0.1800 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.15 | 17.25 | 8484 | 5061 | 1.6763 | 1.1301 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.15 | 17.25 | 86 | 5061 | 0.0170 | 0.2165 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 63.15 | 17.25 | 8540 | 5061 | 1.6874 | 1.1318 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.12 | 17.25 | 66 | 5095 | 0.0130 | 0.1776 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.12 | 17.25 | 8849 | 5095 | 1.7367 | 1.1392 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.12 | 17.25 | 101 | 5095 | 0.0198 | 0.2403 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 65.12 | 17.25 | 8879 | 5095 | 1.7426 | 1.1400 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.09 | 17.25 | 72 | 5221 | 0.0138 | 0.1893 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.09 | 17.25 | 9325 | 5221 | 1.7861 | 1.1458 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.09 | 17.25 | 73 | 5221 | 0.0140 | 0.1913 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.09 | 17.25 | 9209 | 5221 | 1.7638 | 1.1426 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.06 | 17.25 | 77 | 5242 | 0.0147 | 0.1989 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.06 | 17.25 | 9733 | 5242 | 1.8565 | 1.1558 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.06 | 17.25 | 112 | 5242 | 0.0214 | 0.2546 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 69.06 | 17.25 | 9706 | 5242 | 1.8514 | 1.1551 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.03 | 17.25 | 30 | 5367 | 0.0056 | 0.0691 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.03 | 17.25 | 10191 | 5367 | 1.8988 | 1.1610 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.03 | 17.25 | 56 | 5367 | 0.0104 | 0.1528 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 71.03 | 17.25 | 10174 | 5367 | 1.8956 | 1.1606 | MN20160310_N02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.00 | 17.25 | 67 | 5546 | 0.0121 | 0.1769 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.00 | 17.25 | 10626 | 5546 | 1.9157 | 1.1624 | MN20160310_N02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 73.00 | 17.25 | 114 | 5546 | 0.0206 | 0.2545 | MN20160310_N02 | E21 |